Old Republic International Corp decreased its stake in Principal Financial Group (PFG) by 17.03% based on its latest 2019Q1 regulatory filing with the SEC. Old Republic International Corp sold 102,000 shares as the company’s stock rose 11.32% with the market. The institutional investor held 497,000 shares of the accident &health insurance company at the end of 2019Q1, valued at $24.94M, down from 599,000 at the end of the previous reported quarter. Old Republic International Corp who had been investing in Principal Financial Group for a number of months, seems to be less bullish one the $16.64B market cap company. The stock increased 0.05% or $0.03 during the last trading session, reaching $59.73. About 168,137 shares traded. Principal Financial Group, Inc. (NYSE:PFG) has declined 7.33% since July 19, 2018 and is downtrending. It has underperformed by 11.76% the S&P500. Some Historical PFG News: 19/03/2018 – TETRAPHASE PHARMACEUTICALS – BOARD ELECTED CHRISTOPHER WATT AS PRINCIPAL FINANCIAL OFFICER & PRINCIPAL ACCOUNTING OFFICER UNTIL CFO IS NAMED; 26/04/2018 – PRINCIPAL BOOSTS QTR DIV TO 52C/SHR FROM 51C, EST. 51C; 14/05/2018 – Principal Financial Group Inc. Exits Position in Ares Capital; 16/04/2018 – PFG REPORTS PRINCIPAL INTL OTHER ENTITIES AUM $173.8B MARCH 31; 26/04/2018 – B. RILEY FINANCIAL – BEBE’S BOARD ACCEPTED RESIGNATION OF JOE SCIROCCO, ITS PRINCIPAL FINANCIAL & ACCOUNTING OFFICER, EFFECTIVE AS OF APRIL 20; 14/05/2018 – Principal Financial Group Inc. Exits Position in Validus; 02/05/2018 – Principal Names New Chief Human Resources Officer; 22/03/2018 – FLOTEK INDUSTRIES – MATTHEW MARIETTA PROMOTED TO EXECUTIVE VICE PRESIDENT OF FINANCE & CORPORATE DEVELOPMENT, TO SERVE AS PRINCIPAL FINANCIAL OFFICER; 22/05/2018 – ADVISORY-Ignore research alert on Principal Financial Group Inc; 30/03/2018 – BRIEF-Moody’s Corp Says Designated Michael Crimmins To Serve On Interim Basis As Co’s Principal Financial Officer
Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 78.1% based on its latest 2019Q1 regulatory filing with the SEC. Bvf Inc sold 5.22 million shares as the company’s stock rose 15.42% with the market. The hedge fund held 1.46M shares of the health care company at the end of 2019Q1, valued at $20.34 million, down from 6.69M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $471.64 million market cap company. The stock decreased 1.87% or $0.15 during the last trading session, reaching $8.12. About 14,082 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 11.16% since July 19, 2018 and is uptrending. It has outperformed by 6.73% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 ChemoCentryx 4Q EPS 80c; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9
Old Republic International Corp, which manages about $3.71 billion US Long portfolio, upped its stake in Cardinal Health Inc (NYSE:CAH) by 379,000 shares to 1.02M shares, valued at $49.31M in 2019Q1, according to the filing. It also increased its holding in South Jersey Industries Inc (NYSE:SJI) by 472,000 shares in the quarter, for a total of 1.19 million shares, and has risen its stake in Dominion Resources Inc (NYSE:D).
Analysts await Principal Financial Group, Inc. (NASDAQ:PFG) to report earnings on July, 25. They expect $1.38 EPS, up 2.22% or $0.03 from last year’s $1.35 per share. PFG’s profit will be $384.40M for 10.82 P/E if the $1.38 EPS becomes a reality. After $1.43 actual EPS reported by Principal Financial Group, Inc. for the previous quarter, Wall Street now forecasts -3.50% negative EPS growth.
Since February 1, 2019, it had 0 insider buys, and 1 insider sale for $50,170 activity.
Investors sentiment increased to 0.98 in Q1 2019. Its up 0.02, from 0.96 in 2018Q4. It improved, as 29 investors sold PFG shares while 160 reduced holdings. 63 funds opened positions while 123 raised stakes. 194.29 million shares or 1.52% less from 197.29 million shares in 2018Q4 were reported. 649,000 were reported by Ny State Common Retirement Fund. 91,674 are held by Principal Group Inc. 7,353 were reported by Wetherby Asset Mngmt Inc. 74,834 are owned by Hightower Advsrs Limited Liability Corp. Tealwood Asset Management stated it has 53,007 shares or 1.13% of all its holdings. Texas Permanent School Fund holds 0.04% or 50,355 shares. 1,250 were reported by Vigilant Cap Mngmt Lc. Allstate holds 47,518 shares. Asset Mngmt Incorporated holds 0.35% or 9,297 shares in its portfolio. 10,095 are owned by Northwestern Mutual Wealth Management. Optimum Inv Advisors reported 1,819 shares. Eaton Vance Mngmt holds 81,437 shares. Acadian Asset Management Limited Liability Corporation reported 162,538 shares or 0.04% of all its holdings. Gp One Trading Lp reported 173 shares. Mutual Of Omaha Bank & Trust Wealth Management reported 7,326 shares or 0.11% of all its holdings.
More notable recent Principal Financial Group, Inc. (NASDAQ:PFG) news were published by: Nasdaq.com which released: “Zacks.com featured highlights include: Hibbett Sports, Comtech, Quanta Services, Principal Financial and Zions – Nasdaq” on June 24, 2019, also Finance.Yahoo.com with their article: “Here’s What We Think About Principal Financial Group, Inc.’s (NASDAQ:PFG) CEO Pay – Yahoo Finance” published on May 14, 2019, Businesswire.com published: “Principal to Announce Second Quarter 2019 Financial Results – Business Wire” on July 02, 2019. More interesting news about Principal Financial Group, Inc. (NASDAQ:PFG) were released by: Seekingalpha.com and their article: “Principal Financial Group: Nothing Wrong With Growing Inorganically – Seeking Alpha” published on April 15, 2019 as well as Nasdaq.com‘s news article titled: “New Strong Buy Stocks for July 16th – Nasdaq” with publication date: July 16, 2019.
Investors sentiment increased to 1.44 in 2019 Q1. Its up 0.51, from 0.93 in 2018Q4. It is positive, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. The Georgia-based Voya Inv Mgmt Ltd Liability Corporation has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Ameritas Inv Prns invested in 0% or 2,120 shares. Acadian Asset Management Limited Liability Corp reported 0.05% stake. Wells Fargo And Com Mn owns 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 127,125 shares. Employees Retirement Systems Of Texas invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Fincl Bank Of New York Mellon owns 133,619 shares or 0% of their US portfolio. Citigroup stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Panagora Asset invested in 308,857 shares. Arrowstreet Partnership has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Tiaa Cref Inv Management Ltd Company accumulated 288,597 shares. Dekabank Deutsche Girozentrale accumulated 20,000 shares. 207,029 are owned by Baker Bros Advsrs Limited Partnership. 122,039 were reported by Alps Advsrs Inc. Daiwa Securities invested in 0% or 269 shares. Fernwood Inv Mgmt Ltd Liability Co owns 10,000 shares.
Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.21 earnings per share, down 50.00% or $0.07 from last year’s $-0.14 per share. After $-0.23 actual earnings per share reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts -8.70% EPS growth.
Bvf Inc, which manages about $999.89M and $893.07M US Long portfolio, upped its stake in Merus N V by 25,000 shares to 4.54 million shares, valued at $67.06M in 2019Q1, according to the filing. It also increased its holding in Replimune Group Inc by 707,200 shares in the quarter, for a total of 1.61 million shares, and has risen its stake in Molecular Templates Inc.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “InflaRx Update: Pipeline Continues To Progress, Data In 1H 2019 – Seeking Alpha” on November 24, 2018, also Fool.com with their article: “Better Know Biotech: 2 Stocks You Ought to Know About – Motley Fool” published on May 16, 2018, Globenewswire.com published: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” on March 28, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights – GlobeNewswire” published on May 06, 2019 as well as Globenewswire.com‘s news article titled: “ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference – GlobeNewswire” with publication date: September 26, 2018.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.